nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—Furosemide—dilated cardiomyopathy	0.469	1	CrCtD
Indapamide—Bumetanide—Furosemide—dilated cardiomyopathy	0.242	1	CrCrCtD
Indapamide—CA5A—Furosemide—dilated cardiomyopathy	0.0402	0.182	CbGbCtD
Indapamide—CA5B—Furosemide—dilated cardiomyopathy	0.0351	0.158	CbGbCtD
Indapamide—CA7—Furosemide—dilated cardiomyopathy	0.0351	0.158	CbGbCtD
Indapamide—CA9—Furosemide—dilated cardiomyopathy	0.0301	0.136	CbGbCtD
Indapamide—CA12—Furosemide—dilated cardiomyopathy	0.0301	0.136	CbGbCtD
Indapamide—CA4—Furosemide—dilated cardiomyopathy	0.0265	0.12	CbGbCtD
Indapamide—CA2—Furosemide—dilated cardiomyopathy	0.0243	0.11	CbGbCtD
Indapamide—KCNQ1—endocardium—dilated cardiomyopathy	0.00969	0.457	CbGeAlD
Indapamide—CA5B—sinoatrial node—dilated cardiomyopathy	0.00588	0.277	CbGeAlD
Indapamide—KCNE1—TarBasePathway—GJA1—dilated cardiomyopathy	0.00124	0.395	CbGpPWpGaD
Indapamide—KCNE1—heart—dilated cardiomyopathy	0.00117	0.055	CbGeAlD
Indapamide—KCNQ1—myocardium—dilated cardiomyopathy	0.000767	0.0362	CbGeAlD
Indapamide—Oxcarbazepine—SCN5A—dilated cardiomyopathy	0.000579	0.511	CrCbGaD
Indapamide—Furosemide—SLC22A5—dilated cardiomyopathy	0.000554	0.489	CrCbGaD
Indapamide—KCNQ1—heart—dilated cardiomyopathy	0.000536	0.0252	CbGeAlD
Indapamide—KCNQ1—cardiac atrium—dilated cardiomyopathy	0.000458	0.0216	CbGeAlD
Indapamide—KCNQ1—TarBasePathway—GJA1—dilated cardiomyopathy	0.000374	0.119	CbGpPWpGaD
Indapamide—CA4—cardiac ventricle—dilated cardiomyopathy	0.00036	0.017	CbGeAlD
Indapamide—CA5B—heart—dilated cardiomyopathy	0.000343	0.0162	CbGeAlD
Indapamide—CA4—myocardium—dilated cardiomyopathy	0.000339	0.016	CbGeAlD
Indapamide—Ear disorder—Lisinopril—dilated cardiomyopathy	0.000328	0.00778	CcSEcCtD
Indapamide—Blister—Furosemide—dilated cardiomyopathy	0.000327	0.00777	CcSEcCtD
Indapamide—Lethargy—Spironolactone—dilated cardiomyopathy	0.000321	0.00762	CcSEcCtD
Indapamide—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.000308	0.00731	CcSEcCtD
Indapamide—CA2—cardiac ventricle—dilated cardiomyopathy	0.000299	0.0141	CbGeAlD
Indapamide—Ataxia—Spironolactone—dilated cardiomyopathy	0.000296	0.00702	CcSEcCtD
Indapamide—CA5B—cardiac atrium—dilated cardiomyopathy	0.000293	0.0138	CbGeAlD
Indapamide—Glycosuria—Furosemide—dilated cardiomyopathy	0.000291	0.00691	CcSEcCtD
Indapamide—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000283	0.00672	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000283	0.00672	CcSEcCtD
Indapamide—CA2—myocardium—dilated cardiomyopathy	0.000281	0.0132	CbGeAlD
Indapamide—Gastritis—Spironolactone—dilated cardiomyopathy	0.000279	0.00661	CcSEcCtD
Indapamide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000269	0.00637	CcSEcCtD
Indapamide—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.000254	0.00603	CcSEcCtD
Indapamide—Drug interaction—Furosemide—dilated cardiomyopathy	0.000254	0.00603	CcSEcCtD
Indapamide—Gout—Furosemide—dilated cardiomyopathy	0.000253	0.00599	CcSEcCtD
Indapamide—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000251	0.00594	CcSEcCtD
Indapamide—Laryngitis—Lisinopril—dilated cardiomyopathy	0.000246	0.00583	CcSEcCtD
Indapamide—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000243	0.00576	CcSEcCtD
Indapamide—Vasculitis—Furosemide—dilated cardiomyopathy	0.000242	0.00573	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000241	0.00571	CcSEcCtD
Indapamide—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00024	0.0057	CcSEcCtD
Indapamide—Renal failure—Spironolactone—dilated cardiomyopathy	0.000238	0.00566	CcSEcCtD
Indapamide—CA4—heart—dilated cardiomyopathy	0.000237	0.0112	CbGeAlD
Indapamide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000226	0.00537	CcSEcCtD
Indapamide—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000222	0.00526	CcSEcCtD
Indapamide—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.000219	0.00518	CcSEcCtD
Indapamide—Bladder pain—Furosemide—dilated cardiomyopathy	0.000213	0.00506	CcSEcCtD
Indapamide—Urine output increased—Furosemide—dilated cardiomyopathy	0.000213	0.00506	CcSEcCtD
Indapamide—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000211	0.00501	CcSEcCtD
Indapamide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000206	0.00488	CcSEcCtD
Indapamide—CA4—cardiac atrium—dilated cardiomyopathy	0.000202	0.00954	CbGeAlD
Indapamide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000201	0.00478	CcSEcCtD
Indapamide—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000197	0.00467	CcSEcCtD
Indapamide—CA2—heart—dilated cardiomyopathy	0.000196	0.00925	CbGeAlD
Indapamide—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000196	0.00465	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000195	0.0622	CbGpPWpGaD
Indapamide—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000195	0.00463	CcSEcCtD
Indapamide—Polyuria—Furosemide—dilated cardiomyopathy	0.000195	0.00463	CcSEcCtD
Indapamide—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000195	0.00462	CcSEcCtD
Indapamide—Oliguria—Lisinopril—dilated cardiomyopathy	0.000192	0.00456	CcSEcCtD
Indapamide—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000191	0.00454	CcSEcCtD
Indapamide—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000191	0.00453	CcSEcCtD
Indapamide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00019	0.0045	CcSEcCtD
Indapamide—Gout—Lisinopril—dilated cardiomyopathy	0.00019	0.0045	CcSEcCtD
Indapamide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000182	0.00432	CcSEcCtD
Indapamide—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000182	0.00431	CcSEcCtD
Indapamide—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000181	0.0043	CcSEcCtD
Indapamide—KCNQ1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.000181	0.0577	CbGpPWpGaD
Indapamide—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000179	0.00425	CcSEcCtD
Indapamide—Purpura—Furosemide—dilated cardiomyopathy	0.000178	0.00422	CcSEcCtD
Indapamide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000176	0.00417	CcSEcCtD
Indapamide—Lethargy—Furosemide—dilated cardiomyopathy	0.000175	0.00415	CcSEcCtD
Indapamide—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000173	0.0041	CcSEcCtD
Indapamide—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000172	0.00408	CcSEcCtD
Indapamide—Malaise—Spironolactone—dilated cardiomyopathy	0.000171	0.00406	CcSEcCtD
Indapamide—Cystitis—Lisinopril—dilated cardiomyopathy	0.000171	0.00406	CcSEcCtD
Indapamide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00017	0.00403	CcSEcCtD
Indapamide—CA2—cardiac atrium—dilated cardiomyopathy	0.000168	0.00791	CbGeAlD
Indapamide—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.000167	0.00396	CcSEcCtD
Indapamide—Photophobia—Lisinopril—dilated cardiomyopathy	0.000166	0.00394	CcSEcCtD
Indapamide—Irritability—Furosemide—dilated cardiomyopathy	0.000163	0.00388	CcSEcCtD
Indapamide—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00016	0.0038	CcSEcCtD
Indapamide—Discomfort—Spironolactone—dilated cardiomyopathy	0.000159	0.00378	CcSEcCtD
Indapamide—Dehydration—Furosemide—dilated cardiomyopathy	0.000159	0.00378	CcSEcCtD
Indapamide—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000158	0.00376	CcSEcCtD
Indapamide—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000156	0.00371	CcSEcCtD
Indapamide—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000156	0.0037	CcSEcCtD
Indapamide—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000155	0.00368	CcSEcCtD
Indapamide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000155	0.00367	CcSEcCtD
Indapamide—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000154	0.00366	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000154	0.00366	CcSEcCtD
Indapamide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000152	0.00359	CcSEcCtD
Indapamide—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000151	0.00358	CcSEcCtD
Indapamide—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000148	0.0035	CcSEcCtD
Indapamide—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000146	0.00347	CcSEcCtD
Indapamide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000145	0.00344	CcSEcCtD
Indapamide—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000145	0.00344	CcSEcCtD
Indapamide—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000143	0.00339	CcSEcCtD
Indapamide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000142	0.00338	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000139	0.0443	CbGpPWpGaD
Indapamide—Libido decreased—Lisinopril—dilated cardiomyopathy	0.000139	0.00329	CcSEcCtD
Indapamide—Somnolence—Spironolactone—dilated cardiomyopathy	0.000138	0.00326	CcSEcCtD
Indapamide—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000137	0.00324	CcSEcCtD
Indapamide—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.000136	0.00322	CcSEcCtD
Indapamide—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000135	0.00321	CcSEcCtD
Indapamide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000134	0.00317	CcSEcCtD
Indapamide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000134	0.00317	CcSEcCtD
Indapamide—Arthritis—Lisinopril—dilated cardiomyopathy	0.000132	0.00314	CcSEcCtD
Indapamide—Drowsiness—Furosemide—dilated cardiomyopathy	0.000132	0.00313	CcSEcCtD
Indapamide—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000131	0.00311	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000131	0.0031	CcSEcCtD
Indapamide—Renal failure—Furosemide—dilated cardiomyopathy	0.00013	0.00308	CcSEcCtD
Indapamide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000129	0.00306	CcSEcCtD
Indapamide—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000129	0.00305	CcSEcCtD
Indapamide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000128	0.00302	CcSEcCtD
Indapamide—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000127	0.00302	CcSEcCtD
Indapamide—Sweating—Furosemide—dilated cardiomyopathy	0.000127	0.003	CcSEcCtD
Indapamide—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000125	0.00296	CcSEcCtD
Indapamide—Face oedema—Lisinopril—dilated cardiomyopathy	0.000124	0.00294	CcSEcCtD
Indapamide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000123	0.00292	CcSEcCtD
Indapamide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000123	0.00292	CcSEcCtD
Indapamide—Irritability—Lisinopril—dilated cardiomyopathy	0.000123	0.00291	CcSEcCtD
Indapamide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000122	0.0029	CcSEcCtD
Indapamide—Ataxia—Lisinopril—dilated cardiomyopathy	0.000121	0.00287	CcSEcCtD
Indapamide—Dehydration—Lisinopril—dilated cardiomyopathy	0.00012	0.00284	CcSEcCtD
Indapamide—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000117	0.00278	CcSEcCtD
Indapamide—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000117	0.00278	CcSEcCtD
Indapamide—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000116	0.00276	CcSEcCtD
Indapamide—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000116	0.00275	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000116	0.00275	CcSEcCtD
Indapamide—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000115	0.00273	CcSEcCtD
Indapamide—Visual impairment—Furosemide—dilated cardiomyopathy	0.000114	0.00271	CcSEcCtD
Indapamide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000114	0.0027	CcSEcCtD
Indapamide—Gastritis—Lisinopril—dilated cardiomyopathy	0.000114	0.0027	CcSEcCtD
Indapamide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000112	0.00266	CcSEcCtD
Indapamide—Asthma—Lisinopril—dilated cardiomyopathy	0.000111	0.00263	CcSEcCtD
Indapamide—Influenza—Lisinopril—dilated cardiomyopathy	0.000111	0.00263	CcSEcCtD
Indapamide—Tinnitus—Furosemide—dilated cardiomyopathy	0.00011	0.00262	CcSEcCtD
Indapamide—Pruritus—Spironolactone—dilated cardiomyopathy	0.000109	0.0026	CcSEcCtD
Indapamide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000109	0.00258	CcSEcCtD
Indapamide—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000108	0.00257	CcSEcCtD
Indapamide—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000107	0.00253	CcSEcCtD
Indapamide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000106	0.00251	CcSEcCtD
Indapamide—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000106	0.00251	CcSEcCtD
Indapamide—Dysuria—Lisinopril—dilated cardiomyopathy	0.000104	0.00246	CcSEcCtD
Indapamide—Erythema—Furosemide—dilated cardiomyopathy	0.000103	0.00245	CcSEcCtD
Indapamide—Malnutrition—Furosemide—dilated cardiomyopathy	0.000103	0.00245	CcSEcCtD
Indapamide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000102	0.00243	CcSEcCtD
Indapamide—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000102	0.00243	CcSEcCtD
Indapamide—Flatulence—Furosemide—dilated cardiomyopathy	0.000102	0.00241	CcSEcCtD
Indapamide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000101	0.00241	CcSEcCtD
Indapamide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000101	0.0024	CcSEcCtD
Indapamide—Weight decreased—Lisinopril—dilated cardiomyopathy	0.0001	0.00238	CcSEcCtD
Indapamide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.0001	0.00238	CcSEcCtD
Indapamide—Pneumonia—Lisinopril—dilated cardiomyopathy	9.96e-05	0.00236	CcSEcCtD
Indapamide—Muscle spasms—Furosemide—dilated cardiomyopathy	9.92e-05	0.00235	CcSEcCtD
Indapamide—Depression—Lisinopril—dilated cardiomyopathy	9.88e-05	0.00234	CcSEcCtD
Indapamide—Vomiting—Spironolactone—dilated cardiomyopathy	9.84e-05	0.00233	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	9.82e-05	0.00233	CcSEcCtD
Indapamide—Rash—Spironolactone—dilated cardiomyopathy	9.76e-05	0.00231	CcSEcCtD
Indapamide—Dermatitis—Spironolactone—dilated cardiomyopathy	9.75e-05	0.00231	CcSEcCtD
Indapamide—Renal failure—Lisinopril—dilated cardiomyopathy	9.74e-05	0.00231	CcSEcCtD
Indapamide—Vision blurred—Furosemide—dilated cardiomyopathy	9.72e-05	0.00231	CcSEcCtD
Indapamide—Headache—Spironolactone—dilated cardiomyopathy	9.69e-05	0.0023	CcSEcCtD
Indapamide—Jaundice—Lisinopril—dilated cardiomyopathy	9.65e-05	0.00229	CcSEcCtD
Indapamide—Urinary tract infection—Lisinopril—dilated cardiomyopathy	9.63e-05	0.00228	CcSEcCtD
Indapamide—Anaemia—Furosemide—dilated cardiomyopathy	9.53e-05	0.00226	CcSEcCtD
Indapamide—Sweating—Lisinopril—dilated cardiomyopathy	9.49e-05	0.00225	CcSEcCtD
Indapamide—Agitation—Furosemide—dilated cardiomyopathy	9.48e-05	0.00225	CcSEcCtD
Indapamide—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	9.37e-05	0.00222	CcSEcCtD
Indapamide—Sinusitis—Lisinopril—dilated cardiomyopathy	9.29e-05	0.0022	CcSEcCtD
Indapamide—Vertigo—Furosemide—dilated cardiomyopathy	9.27e-05	0.0022	CcSEcCtD
Indapamide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	9.24e-05	0.00219	CcSEcCtD
Indapamide—Leukopenia—Furosemide—dilated cardiomyopathy	9.23e-05	0.00219	CcSEcCtD
Indapamide—Nausea—Spironolactone—dilated cardiomyopathy	9.19e-05	0.00218	CcSEcCtD
Indapamide—Rhinitis—Lisinopril—dilated cardiomyopathy	8.91e-05	0.00211	CcSEcCtD
Indapamide—Hepatitis—Lisinopril—dilated cardiomyopathy	8.89e-05	0.00211	CcSEcCtD
Indapamide—Pharyngitis—Lisinopril—dilated cardiomyopathy	8.82e-05	0.00209	CcSEcCtD
Indapamide—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	8.78e-05	0.00208	CcSEcCtD
Indapamide—Oedema peripheral—Lisinopril—dilated cardiomyopathy	8.76e-05	0.00208	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	8.72e-05	0.00207	CcSEcCtD
Indapamide—Urethral disorder—Lisinopril—dilated cardiomyopathy	8.72e-05	0.00207	CcSEcCtD
Indapamide—Dry mouth—Furosemide—dilated cardiomyopathy	8.59e-05	0.00204	CcSEcCtD
Indapamide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	8.42e-05	0.002	CcSEcCtD
Indapamide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	8.41e-05	0.00199	CcSEcCtD
Indapamide—Tinnitus—Lisinopril—dilated cardiomyopathy	8.29e-05	0.00197	CcSEcCtD
Indapamide—Shock—Furosemide—dilated cardiomyopathy	8.28e-05	0.00196	CcSEcCtD
Indapamide—Nervous system disorder—Furosemide—dilated cardiomyopathy	8.26e-05	0.00196	CcSEcCtD
Indapamide—Flushing—Lisinopril—dilated cardiomyopathy	8.25e-05	0.00196	CcSEcCtD
Indapamide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	8.24e-05	0.00196	CcSEcCtD
Indapamide—Skin disorder—Furosemide—dilated cardiomyopathy	8.18e-05	0.00194	CcSEcCtD
Indapamide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	8.14e-05	0.00193	CcSEcCtD
Indapamide—Anorexia—Furosemide—dilated cardiomyopathy	8.02e-05	0.0019	CcSEcCtD
Indapamide—Arrhythmia—Lisinopril—dilated cardiomyopathy	7.94e-05	0.00188	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—ABCC9—dilated cardiomyopathy	7.91e-05	0.0252	CbGpPWpGaD
Indapamide—Hypotension—Furosemide—dilated cardiomyopathy	7.87e-05	0.00187	CcSEcCtD
Indapamide—Erythema—Lisinopril—dilated cardiomyopathy	7.74e-05	0.00184	CcSEcCtD
Indapamide—Malnutrition—Lisinopril—dilated cardiomyopathy	7.74e-05	0.00184	CcSEcCtD
Indapamide—Flatulence—Lisinopril—dilated cardiomyopathy	7.63e-05	0.00181	CcSEcCtD
Indapamide—Tension—Lisinopril—dilated cardiomyopathy	7.59e-05	0.0018	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—ACTN2—dilated cardiomyopathy	7.58e-05	0.0241	CbGpPWpGaD
Indapamide—Dysgeusia—Lisinopril—dilated cardiomyopathy	7.58e-05	0.0018	CcSEcCtD
Indapamide—Paraesthesia—Furosemide—dilated cardiomyopathy	7.56e-05	0.00179	CcSEcCtD
Indapamide—Nervousness—Lisinopril—dilated cardiomyopathy	7.52e-05	0.00178	CcSEcCtD
Indapamide—Back pain—Lisinopril—dilated cardiomyopathy	7.49e-05	0.00178	CcSEcCtD
Indapamide—Somnolence—Furosemide—dilated cardiomyopathy	7.48e-05	0.00178	CcSEcCtD
Indapamide—Muscle spasms—Lisinopril—dilated cardiomyopathy	7.44e-05	0.00177	CcSEcCtD
Indapamide—Decreased appetite—Furosemide—dilated cardiomyopathy	7.32e-05	0.00174	CcSEcCtD
Indapamide—Vision blurred—Lisinopril—dilated cardiomyopathy	7.29e-05	0.00173	CcSEcCtD
Indapamide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	7.27e-05	0.00172	CcSEcCtD
Indapamide—Fatigue—Furosemide—dilated cardiomyopathy	7.26e-05	0.00172	CcSEcCtD
Indapamide—Constipation—Furosemide—dilated cardiomyopathy	7.2e-05	0.00171	CcSEcCtD
Indapamide—Pain—Furosemide—dilated cardiomyopathy	7.2e-05	0.00171	CcSEcCtD
Indapamide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	7.18e-05	0.0017	CcSEcCtD
Indapamide—Anaemia—Lisinopril—dilated cardiomyopathy	7.15e-05	0.0017	CcSEcCtD
Indapamide—Angioedema—Lisinopril—dilated cardiomyopathy	7.07e-05	0.00168	CcSEcCtD
Indapamide—Malaise—Lisinopril—dilated cardiomyopathy	6.98e-05	0.00166	CcSEcCtD
Indapamide—Vertigo—Lisinopril—dilated cardiomyopathy	6.95e-05	0.00165	CcSEcCtD
Indapamide—Syncope—Lisinopril—dilated cardiomyopathy	6.94e-05	0.00165	CcSEcCtD
Indapamide—Feeling abnormal—Furosemide—dilated cardiomyopathy	6.94e-05	0.00165	CcSEcCtD
Indapamide—Leukopenia—Lisinopril—dilated cardiomyopathy	6.93e-05	0.00164	CcSEcCtD
Indapamide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	6.88e-05	0.00163	CcSEcCtD
Indapamide—Palpitations—Lisinopril—dilated cardiomyopathy	6.84e-05	0.00162	CcSEcCtD
Indapamide—Loss of consciousness—Lisinopril—dilated cardiomyopathy	6.8e-05	0.00161	CcSEcCtD
Indapamide—Cough—Lisinopril—dilated cardiomyopathy	6.75e-05	0.0016	CcSEcCtD
Indapamide—Urticaria—Furosemide—dilated cardiomyopathy	6.69e-05	0.00159	CcSEcCtD
Indapamide—Abdominal pain—Furosemide—dilated cardiomyopathy	6.65e-05	0.00158	CcSEcCtD
Indapamide—Body temperature increased—Furosemide—dilated cardiomyopathy	6.65e-05	0.00158	CcSEcCtD
Indapamide—Chest pain—Lisinopril—dilated cardiomyopathy	6.59e-05	0.00156	CcSEcCtD
Indapamide—Arthralgia—Lisinopril—dilated cardiomyopathy	6.59e-05	0.00156	CcSEcCtD
Indapamide—Myalgia—Lisinopril—dilated cardiomyopathy	6.59e-05	0.00156	CcSEcCtD
Indapamide—Anxiety—Lisinopril—dilated cardiomyopathy	6.57e-05	0.00156	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	6.54e-05	0.00155	CcSEcCtD
Indapamide—Discomfort—Lisinopril—dilated cardiomyopathy	6.51e-05	0.00154	CcSEcCtD
Indapamide—Dry mouth—Lisinopril—dilated cardiomyopathy	6.44e-05	0.00153	CcSEcCtD
Indapamide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	6.32e-05	0.0015	CcSEcCtD
Indapamide—Oedema—Lisinopril—dilated cardiomyopathy	6.32e-05	0.0015	CcSEcCtD
Indapamide—Infection—Lisinopril—dilated cardiomyopathy	6.28e-05	0.00149	CcSEcCtD
Indapamide—Shock—Lisinopril—dilated cardiomyopathy	6.21e-05	0.00147	CcSEcCtD
Indapamide—Hypersensitivity—Furosemide—dilated cardiomyopathy	6.2e-05	0.00147	CcSEcCtD
Indapamide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	6.18e-05	0.00147	CcSEcCtD
Indapamide—Tachycardia—Lisinopril—dilated cardiomyopathy	6.16e-05	0.00146	CcSEcCtD
Indapamide—Skin disorder—Lisinopril—dilated cardiomyopathy	6.14e-05	0.00146	CcSEcCtD
Indapamide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	6.11e-05	0.00145	CcSEcCtD
Indapamide—Asthenia—Furosemide—dilated cardiomyopathy	6.04e-05	0.00143	CcSEcCtD
Indapamide—Anorexia—Lisinopril—dilated cardiomyopathy	6.02e-05	0.00143	CcSEcCtD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	5.96e-05	0.019	CbGpPWpGaD
Indapamide—Pruritus—Furosemide—dilated cardiomyopathy	5.96e-05	0.00141	CcSEcCtD
Indapamide—Hypotension—Lisinopril—dilated cardiomyopathy	5.9e-05	0.0014	CcSEcCtD
Indapamide—Diarrhoea—Furosemide—dilated cardiomyopathy	5.76e-05	0.00137	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	5.75e-05	0.00137	CcSEcCtD
Indapamide—Insomnia—Lisinopril—dilated cardiomyopathy	5.71e-05	0.00136	CcSEcCtD
Indapamide—Paraesthesia—Lisinopril—dilated cardiomyopathy	5.67e-05	0.00135	CcSEcCtD
Indapamide—Dyspnoea—Lisinopril—dilated cardiomyopathy	5.63e-05	0.00134	CcSEcCtD
Indapamide—Somnolence—Lisinopril—dilated cardiomyopathy	5.62e-05	0.00133	CcSEcCtD
Indapamide—Dizziness—Furosemide—dilated cardiomyopathy	5.57e-05	0.00132	CcSEcCtD
Indapamide—Dyspepsia—Lisinopril—dilated cardiomyopathy	5.56e-05	0.00132	CcSEcCtD
Indapamide—Decreased appetite—Lisinopril—dilated cardiomyopathy	5.49e-05	0.0013	CcSEcCtD
Indapamide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	5.45e-05	0.00129	CcSEcCtD
Indapamide—Fatigue—Lisinopril—dilated cardiomyopathy	5.45e-05	0.00129	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	5.44e-05	0.0173	CbGpPWpGaD
Indapamide—Constipation—Lisinopril—dilated cardiomyopathy	5.4e-05	0.00128	CcSEcCtD
Indapamide—Pain—Lisinopril—dilated cardiomyopathy	5.4e-05	0.00128	CcSEcCtD
Indapamide—Vomiting—Furosemide—dilated cardiomyopathy	5.35e-05	0.00127	CcSEcCtD
Indapamide—Rash—Furosemide—dilated cardiomyopathy	5.31e-05	0.00126	CcSEcCtD
Indapamide—Dermatitis—Furosemide—dilated cardiomyopathy	5.3e-05	0.00126	CcSEcCtD
Indapamide—Headache—Furosemide—dilated cardiomyopathy	5.27e-05	0.00125	CcSEcCtD
Indapamide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	5.21e-05	0.00123	CcSEcCtD
Indapamide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	5.17e-05	0.00123	CcSEcCtD
Indapamide—Urticaria—Lisinopril—dilated cardiomyopathy	5.02e-05	0.00119	CcSEcCtD
Indapamide—Nausea—Furosemide—dilated cardiomyopathy	5e-05	0.00119	CcSEcCtD
Indapamide—Abdominal pain—Lisinopril—dilated cardiomyopathy	4.99e-05	0.00118	CcSEcCtD
Indapamide—Body temperature increased—Lisinopril—dilated cardiomyopathy	4.99e-05	0.00118	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	4.71e-05	0.015	CbGpPWpGaD
Indapamide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	4.65e-05	0.0011	CcSEcCtD
Indapamide—Asthenia—Lisinopril—dilated cardiomyopathy	4.53e-05	0.00108	CcSEcCtD
Indapamide—Pruritus—Lisinopril—dilated cardiomyopathy	4.47e-05	0.00106	CcSEcCtD
Indapamide—Diarrhoea—Lisinopril—dilated cardiomyopathy	4.32e-05	0.00103	CcSEcCtD
Indapamide—Dizziness—Lisinopril—dilated cardiomyopathy	4.18e-05	0.000991	CcSEcCtD
Indapamide—Vomiting—Lisinopril—dilated cardiomyopathy	4.02e-05	0.000953	CcSEcCtD
Indapamide—Rash—Lisinopril—dilated cardiomyopathy	3.98e-05	0.000945	CcSEcCtD
Indapamide—Dermatitis—Lisinopril—dilated cardiomyopathy	3.98e-05	0.000944	CcSEcCtD
Indapamide—Headache—Lisinopril—dilated cardiomyopathy	3.96e-05	0.000939	CcSEcCtD
Indapamide—Nausea—Lisinopril—dilated cardiomyopathy	3.75e-05	0.00089	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.11e-05	0.00992	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.03e-05	0.00965	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.03e-05	0.00965	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.82e-05	0.00897	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ANKRD1—dilated cardiomyopathy	2.56e-05	0.00815	CbGpPWpGaD
Indapamide—CA5A—Metabolism—TAZ—dilated cardiomyopathy	2.41e-05	0.00767	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ANKRD1—dilated cardiomyopathy	2.39e-05	0.00761	CbGpPWpGaD
Indapamide—CA7—Metabolism—ANKRD1—dilated cardiomyopathy	2.39e-05	0.00761	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TAZ—dilated cardiomyopathy	2.25e-05	0.00716	CbGpPWpGaD
Indapamide—CA7—Metabolism—TAZ—dilated cardiomyopathy	2.25e-05	0.00716	CbGpPWpGaD
Indapamide—CA12—Metabolism—ANKRD1—dilated cardiomyopathy	2.21e-05	0.00705	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SDHA—dilated cardiomyopathy	2.18e-05	0.00693	CbGpPWpGaD
Indapamide—CA12—Metabolism—TAZ—dilated cardiomyopathy	2.08e-05	0.00663	CbGpPWpGaD
Indapamide—CA7—Metabolism—SDHA—dilated cardiomyopathy	2.03e-05	0.00647	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SDHA—dilated cardiomyopathy	2.03e-05	0.00647	CbGpPWpGaD
Indapamide—CA12—Metabolism—SDHA—dilated cardiomyopathy	1.88e-05	0.006	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.79e-05	0.00571	CbGpPWpGaD
Indapamide—CA4—Metabolism—ANKRD1—dilated cardiomyopathy	1.77e-05	0.00562	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—RAF1—dilated cardiomyopathy	1.73e-05	0.00549	CbGpPWpGaD
Indapamide—CA2—Metabolism—ANKRD1—dilated cardiomyopathy	1.69e-05	0.00539	CbGpPWpGaD
Indapamide—CA4—Metabolism—TAZ—dilated cardiomyopathy	1.66e-05	0.00529	CbGpPWpGaD
Indapamide—CA2—Metabolism—TAZ—dilated cardiomyopathy	1.59e-05	0.00507	CbGpPWpGaD
Indapamide—CA4—Metabolism—SDHA—dilated cardiomyopathy	1.5e-05	0.00478	CbGpPWpGaD
Indapamide—CA2—Metabolism—SDHA—dilated cardiomyopathy	1.44e-05	0.00458	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—SOD2—dilated cardiomyopathy	1.43e-05	0.00457	CbGpPWpGaD
Indapamide—CA9—Metabolism—ANKRD1—dilated cardiomyopathy	1.43e-05	0.00454	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—GPX1—dilated cardiomyopathy	1.37e-05	0.00436	CbGpPWpGaD
Indapamide—CA9—Metabolism—TAZ—dilated cardiomyopathy	1.34e-05	0.00427	CbGpPWpGaD
Indapamide—CA9—Metabolism—SDHA—dilated cardiomyopathy	1.21e-05	0.00386	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.14e-06	0.00196	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GPX1—dilated cardiomyopathy	5.92e-06	0.00188	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CD36—dilated cardiomyopathy	5.76e-06	0.00183	CbGpPWpGaD
Indapamide—CA7—Metabolism—GPX1—dilated cardiomyopathy	5.52e-06	0.00176	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GPX1—dilated cardiomyopathy	5.52e-06	0.00176	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CD36—dilated cardiomyopathy	5.38e-06	0.00171	CbGpPWpGaD
Indapamide—CA7—Metabolism—CD36—dilated cardiomyopathy	5.38e-06	0.00171	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AGT—dilated cardiomyopathy	5.19e-06	0.00165	CbGpPWpGaD
Indapamide—CA12—Metabolism—GPX1—dilated cardiomyopathy	5.12e-06	0.00163	CbGpPWpGaD
Indapamide—CA12—Metabolism—CD36—dilated cardiomyopathy	4.98e-06	0.00159	CbGpPWpGaD
Indapamide—CA7—Metabolism—AGT—dilated cardiomyopathy	4.84e-06	0.00154	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AGT—dilated cardiomyopathy	4.84e-06	0.00154	CbGpPWpGaD
Indapamide—CA12—Metabolism—AGT—dilated cardiomyopathy	4.49e-06	0.00143	CbGpPWpGaD
Indapamide—CA4—Metabolism—GPX1—dilated cardiomyopathy	4.08e-06	0.0013	CbGpPWpGaD
Indapamide—CA4—Metabolism—CD36—dilated cardiomyopathy	3.97e-06	0.00127	CbGpPWpGaD
Indapamide—CA2—Metabolism—GPX1—dilated cardiomyopathy	3.91e-06	0.00125	CbGpPWpGaD
Indapamide—CA2—Metabolism—CD36—dilated cardiomyopathy	3.81e-06	0.00121	CbGpPWpGaD
Indapamide—CA4—Metabolism—AGT—dilated cardiomyopathy	3.58e-06	0.00114	CbGpPWpGaD
Indapamide—CA2—Metabolism—AGT—dilated cardiomyopathy	3.43e-06	0.00109	CbGpPWpGaD
Indapamide—CA9—Metabolism—GPX1—dilated cardiomyopathy	3.3e-06	0.00105	CbGpPWpGaD
Indapamide—CA9—Metabolism—CD36—dilated cardiomyopathy	3.21e-06	0.00102	CbGpPWpGaD
Indapamide—CA9—Metabolism—AGT—dilated cardiomyopathy	2.89e-06	0.00092	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.4e-06	0.000765	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.26e-06	0.000719	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.04e-06	0.00065	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.55e-07	0.000177	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.41e-07	0.000172	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.87e-07	0.000155	CbGpPWpGaD
